Bagossi Péter

1.

Mótyán, J. A., Bagossi, P., Benkő, S., Tőzsér, J.: A molecular model of the full-length human NOD-like receptor family CARD domain containing 5 (NLRC5) protein.
BMC Bioinformatics. 14 (1), 1-11, 2013.

doi DEA

Journal metrics:

D1 Applied Mathematics

Q1 Biochemistry

D1 Computer Science Applications

Q2 Molecular Biology

Q2 Structural Biology

2.

Simon-Vecsei, Z., Király, R., Bagossi, P., Tóth, B., Dahlbom, I., Caja, S., Csősz, É., Lindfors, K., Sblattero, D., Nemes, É., Mäki, M., Fésüs, L., Korponay-Szabó, I.: A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
PNAS USA 109 (2), 431-436, 2012.

doi DEA

Journal metrics:

D1 Multidisciplinary

3.

Lajszné Tóth, B., Erdős, M., Székely, A., Ritli, L., Bagossi, P., Sümegi, J., Maródi, L.: Molecular genetic characterization of novel sphingomyelin phosphodiesterase 1 mutations causing Niemann-Pick disease.
JIMD Rep. 3, 125-129, 2012.

doi DEA

4.

Ádám, C., Erdei, É., Casado, C., Kovács, L., Gonzalez, A., Majoros, L., Petrényi, K., Bagossi, P., Farkas, I., Molnár, M., Pócsi, I., Ariño, J., Dombrádi, V.: Protein phosphatase CaPpz1 is involved in cation homeostasis, cell wall integrity and virulence of Candida albicans.
Microbiology (Reading, Engl.). 158 (5), 1258-1267, 2012.

doi DEA

Journal metrics:

Q1 Microbiology

5.

Steiber, Z., Silver, D. M., Tőzsér, J., Bagossi, P., Jakab, A., Berta, A., Csutak, A.: Relationships between estradiol, progesterone, and plasminogen activator inhibitor longitudinally during normal human pregnancy.
Acta Ophthalmol. 90 (S249), T001, 2012.

doi DEA

6.

Mótyán, J. A., Gyémánt, G., Harangi, J., Bagossi, P.: Computer-aided subsite mapping of alpha-amylases.
Carbohydr. Res. 346 (3), 410-415, 2011.

doi DEA

Journal metrics:

Q2 Analytical Chemistry

Q3 Biochemistry

Q2 Medicine (miscellaneous)

Q2 Organic Chemistry

7.

Austin, B. P., Tőzsér, J., Bagossi, P., Tropea, J. E., Waugh, D. S.: The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: insights into their use as tools for the removal of affinity tags.
Protein Expr. Purif. 77 (1), 53-61, 2011.

doi DEA

Journal metrics:

Q2 Biotechnology

8.

Mótyán, J. A., Fazekas, E., Mori, H., Svensson, B., Bagossi, P., Kandra, L., Gyémánt, G.: Transglycosylation by barley alfa-amylase 1.
J. Mol. Catal. B-Enzym. 72 (3-4), 229-237, 2011.

doi DEA

Journal metrics:

Q2 Biochemistry

Q2 Bioengineering

Q3 Catalysis

Q1 Process Chemistry and Technology

9.

Korponay-Szabó, I., Fésüs, L., Bagossi, P., Bagossi, P., Csősz, É., Király, R., Simon-Vecsei, Z., Mäki, M.: Diagnosis of gluten-induced autoimmune diseases.

DEA

10.

Bagossi, P., Bander, P., Bozóki, B., Tőzsér, J.: Discovery and significance of new Human T-lymphotropic viruses: HTVL-3 and HTLV-4.
Expert Rev. Anti. Infect. Ther. 7 (10), 1235-1249, 2009.

DEA

Journal metrics:

Q2 Infectious Diseases

Q2 Microbiology

Q2 Microbiology (medical)

Q2 Virology

11.

Boross, P., Bagossi, P., Weber, I. T., Tőzsér, J.: Drug targets in human T-lymphotropic virus type 1 (HTLV-1) infection.
Inf. Dis. Drug Targets. 9 (2), 159-171, 2009.

DEA

Journal metrics:

Q1 Medicine (miscellaneous)

Q1 Microbiology (medical)

Q2 Molecular Medicine

Q1 Pharmacology

12.

Eizert, E. H., Bander, P., Bagossi, P., Sperka, T., Miklóssy, G., Boross, P., Weber, I. T., Tőzsér, J.: Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
J. Virol. 82 (20), 10111-10117, 2008.

doi DEA

Journal metrics:

D1 Immunology

D1 Insect Science

D1 Microbiology

D1 Virology

13.

Kókai, E., Bagossi, P., Dombrádi, V.: A protein foszfatáz 1, egy sokoldalú ősi enzim = Protein phosphatase 1, a versatile ancient enzyme.
Biokémia. 32 (2), 22-34, 2008.

DEA

14.

Kádas, J., Boross, P., Weber, I. T., Bagossi, P., Matúz, K., Tőzsér, J.: C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.
Biochem. J. 416 (3), 357-364, 2008.

doi DEA

Journal metrics:

D1 Biochemistry

Q1 Cell Biology

Q1 Molecular Biology

15.

Miklóssy, G., Tőzsér, J., Kádas, J., Ishima, R., Louis, J. M., Bagossi, P.: Novel macromolecular inhibitors of human immunodeficiency virus-l protease.
Protein Eng. Des. Sel. 21 (7), 453-461, 2008.

doi DEA

Journal metrics:

Q1 Biochemistry

Q1 Bioengineering

Q1 Biotechnology

Q2 Molecular Biology

16.

Kakuk, A., Friedländer, E., Vereb, G., Lisboa, D., Bagossi, P., Tóth, G., Gergely, P., Vereb, G.: Nuclear and nucleolar localization signals and their targeting function in phosphatidylinositol 4-kinase PI4K230.
Exp. Cell Res. 314 (13), 2376-2388, 2008.

doi DEA

Journal metrics:

Q1 Cell Biology

17.

Csutak, A., Silver, D. M., Tőzsér, J., Steiber, Z., Bagossi, P., Hassan, Z., Berta, A.: Plasminogen activator inhibitor in human tears after laser refractive surgery.
J. Cataract. Refract. Surg. 34 (6), 897-901, 2008.

doi DEA

Journal metrics:

D1 Ophthalmology

Q1 Sensory Systems

D1 Surgery

18.

Csősz, É., Bagossi, P., Nagy, Z., Dosztányi, Z., Simon, I., Fésüs, L.: Substrate preference of transglutaminase 2 revealed by logistic regression analysis and intrinsic disorder examination.
J. Mol. Biol. 383 (2), 390-402, 2008.

doi DEA

Journal metrics:

Q1 Molecular Biology

Q1 Structural Biology

19.

Sperka, T., Miklóssy, G., Tie, Y., Bagossi, P., Zahuczky, G., Boross, P., Matúz, K., Harrison, R. W., Weber, I. T., Tőzsér, J.: Bovine leukemia virus protease: comparison with human T-lymphotropic virus and human immunodeficiency virus protease.
J. Gen. Virol. 88 (7), 2052-2063, 2007.

doi DEA

Journal metrics:

Q1 Virology

20.

Varga, A., Bagossi, P., Tőzsér, J., Peitl, B., Szilvássy, Z.: Effect of experimental hypercholesterolaemia on K+ channel alpha-subunit mRNA levels in rabbit hearts.
Eur. J. Pharmacol. 562 (1-2), 130-131, 2007.

doi DEA

Journal metrics:

Q2 Pharmacology

21.

Fehér, A., Boross, P., Sperka, T., Miklóssy, G., Kádas, J., Bagossi, P., Oroszlan, S., Weber, I. T., Tőzsér, J.: Characterization of the murine leukemia virus protease and its comparison with the human immunodeficiency virus type 1 protease.
J. Gen. Virol. 87 (5), 1321-1330, 2006.

doi DEA

Journal metrics:

Q1 Virology

22.

Sperka, T., Boross, P., Eizert, E. H., Tőzsér, J., Bagossi, P.: Effect of mutations on the dimer stability and the pH optimum of the human foamy virus protease.
Protein Eng. Des. Sel. 19 (8), 369-375, 2006.

doi DEA

Journal metrics:

Q2 Biochemistry

Q1 Bioengineering

Q1 Biotechnology

Q2 Molecular Biology

23.

Boross, P., Tőzsér, J., Bagossi, P.: Improved purification protocol for wild-type and mutant human foamy virus proteases.
Protein Expr. Purif. 46 (2), 343-347, 2006.

doi DEA

Journal metrics:

Q2 Biotechnology

24.

Bagossi, P., Sperka, T., Fehér, A., Kádas, J., Zahuczky, G., Miklóssy, G., Boross, P., Tőzsér, J.: Amino Acid Preferences for a Critical Substrate Binding Subsite of Retroviral Proteases in Type 1 Cleavage Sites.
J. Virol. 79 (7), 4213-4218, 2005.

doi DEA

Journal metrics:

D1 Immunology

D1 Insect Science

D1 Microbiology

D1 Virology

25.

Csősz, É., Bagossi, P., Fésüs, L.: An in silico study of substrate preference for transglutaminase 2.
FEBS J. 272 (Suppl1), 410-410, 2005.

doi DEA